Barbara B. Mittleman, M.D. is the Director of NIH’s (National Institutes of Health) Public-Private Partnership Program. In that capacity, she oversees activities to develop and implement policy, to facilitate access of NIH and a wide range of outside partners from industry, public advocacy, professional societies and government agencies to one another, and promotes the partnership from inception to launch to manifestation. She was instrumental in the negotiations that led to the formation of The Biomarkers Consortium, co-chaired the first mHealth Summit in 2009, and works closely with NIH Institutes and Centers to enhance partnership opportunities and success. Her training is in internal medicine and rheumatology, encompassing both clinical and basic science aspects of autoimmunity. She graduated from the University of Pittsburgh Medical School and completed residency and fellowship training there. She came to NIH in 1991 to pursue post-doctoral training in cellular immunology, eventually heading up a laboratory in the National Institute of Mental Health focusing on the immunology of psychiatric disease. She then moved to the National Institute of Arthritis and Musculoskeletal and Skin Diseases as the Director of Scientific Interchange, where she facilitated partnerships, one of which involved the founding of a community research clinic and partnerships with some 60 plus community organization. She came to the NIH Office of the Director, Office of Science Policy in 2005, at the inauguration of the Program on Public-Private Partnerships as the founding director. Her publications include work in the cellular immune aspects of autoimmune and psychiatric disease, health disparities, and partnerships.